모집분야

Biochemistry, Immunology, Molecular Biology, Cell Biology, Pharmacology, hematology, Stem cell biology, RNA biology

생명과학 전분야

수행중 혹은 예정된 과제

1. 세포 정지 현상(Cell quiescence) 의 ‘새로운 패러다임’을 제시하는 창의적인 연구

2. T 세포가 관련된 질환 모델 연구 (염증질환, 자가면역질환, 알레르기, 당뇨병, 암)

3. Ciliopathy 와 metabolic diseases/autoimmune diseases 융합연구

4. Tubulin homeostasis와 Immunity 융합연구

4. 알레르기성 질환 (아토피, 천식) 연구와 치료제 개발

• 면역학 전공 뿐 아니라, 생화학, 세포생물학, 분자생물학, 약학, 줄기세포학, 혈액학 등 다양한 전문분야의 연구자 환영.
• 동물실험 가능자.
• 다양한 분자생물학적 실험 기법에 익숙한 분 우대.
• 책임감 있는 연구자 우대

황수석 교수 대표업적 참조

1. Hwang SS*, Lim J*, Yu Z, Kong P, Sefik E, Xu H, Harman CCD, Kim LK, Lee GR, Li H, Flavell RA “mRNA destabilization by BTG1 and BTG2 maintains T cell quiescence” Science (2020) Mar 13;367(6483):1255-1260. (*co-first) (IF : 41.845)  
2. Jang SW*, Hwang SS*, Kim HS , Kim MK, Lee WH, Hwang SU, Gwak J, Yew SK, Flavell RA, Lee GR. “Homeobox protein Hhex negatively regulates Treg cells by inhibiting Foxp3 expression and function” Proceedings of National Academy of Science (2019) Dec;116(51):25790-25799. (*co-first) (IF : 9.412) 
3. Hwang SS*, Jang SW*, Lee KO, Kim HS, Lee GR. “RHS6 coordinately regulates the Th2 cytokine genes by recruiting GATA3, SATB1, and IRF4” Allergy (2017) May;72(5):772-782 (*co-first) (IF : 8.706) 
4. Hwang SS, Jang SW, Kim MK, Kim LK, Kim BS, Kim HS, Kim K, Lee W, Flavell RA, Lee GR. “YY1 inhibits differentiation and function of regulatory T cells by blocking Foxp3 expression and activity” Nature Communications (2016) 7:10789 (IF : 12.121) 
5. Hwang SS, Kim YU, Lee S, Jang SW, Kim MK, Koh BH, Lee W, Kim J, Souabni A, Busslinger M, Lee GR. "Transcription factor YY1 is essential for regulation of the Th2 cytokine locus and for Th2 cell differentiation" Proceedings of National Academy of Science (2012) 110(1):276-81 (IF : 9.412)
6. Koh BH*, Hwang SS*, Kim JY, Lee W, Kang MJ, Lee CG, Park JW, Flavell RA, Lee GR. "Th2 LCR is essential for regulation of Th2 cytokine genes and for pathogenesis of allergic asthma" Proceedings of National Academy of Science (2010) 107(23):10614-9 (*co-first) (IF : 9.412)